Myomo (MYO) Long-Term Debt Repayments (2017 - 2020)
Myomo posted quarterly Long-Term Debt Repayments of $1.7 million for Q1 2020, up 67.19% on a QoQ basis from $1.0 million in Q4 2017.
Myomo (MYO) has 2 years of Long-Term Debt Repayments data on file, last reported at $1.7 million in Q1 2020.
- For the quarter ending Q1 2020, Long-Term Debt Repayments changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2020 stood at $1.7 million (changed N/A YoY), and the FY2020 full-year result was $1.7 million, changed N/A from the prior year.
- Long-Term Debt Repayments for Q1 2020 stood at $1.7 million, up from $1.0 million in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $1.7 million in Q1 2020 and bottomed at $142869.0 in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.70 Mn |
| Mar 31, 2020 | 1.70 Mn |
| Dec 31, 2017 | 1.02 Mn |
| Dec 31, 2017 | 1.02 Mn |
| Sep 30, 2017 | 142,869.00 |
| Sep 30, 2017 | 142,869.00 |